Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00534B100 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
ADAR1 Capital Management, LLC
13G/A
Amendment 1
|
5.4% |
8/14/2026
Event 6/30/2026
|
|
| ADAR1 Capital Management, LLC | 5.4% | ||
| Daniel Schneeberger | 5.4% | ||
| Sio Capital Management, LLC 13G/A Amendment 1 | 3.2% |
7/28/2026
Event 6/30/2026
|
|
|
Perceptive Advisors LLC
13G/A
Amendment 3
|
55.4% |
5/15/2026
Event 3/31/2026
|
|
| Perceptive Advisors LLC | 55.4% | ||
| Joseph Edelman | 55.4% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 54.7% | ||
| C2 Life Sciences LLC | 0.9% | ||
|
Adage Capital Management, L.P.
13G/A
Amendment 2
|
5.7% |
5/13/2026
Event 3/31/2026
|
|
| Adage Capital Management, L.P. | 5.7% | ||
| Robert Atchinson | 5.7% | ||
| Phillip Gross | 5.7% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 2
|
57.5% |
2/17/2026
Event 12/31/2025
|
|
| Perceptive Advisors LLC | 57.5% | ||
| Joseph Edelman | 57.5% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 56.8% | ||
| C2 Life Sciences LLC | 0.8% | ||
|
Alyeska Investment Group, L.P.
13G
|
9.9% |
2/17/2026
Event 12/31/2025
|
|
| Alyeska Investment Group, L.P. | 9.9% | ||
| Alyeska Fund GP, LLC | 9.9% | ||
| Anand Parekh | 9.9% | ||
|
ADAR1 Capital Management, LLC
13G
|
5.7% |
2/17/2026
Event 12/31/2025
|
|
| ADAR1 Capital Management, LLC | 5.7% | ||
| Daniel Schneeberger | 5.7% | ||
| Sio Capital Management, LLC 13G | 6.1% |
2/11/2026
Event 12/31/2025
|
|
|
Adage Capital Management, L.P.
13G/A
Amendment 1
|
6.9% |
11/13/2025
Event 9/30/2025
|
|
| Adage Capital Management, L.P. | 6.9% | ||
| Robert Atchinson | 6.9% | ||
| Phillip Gross | 6.9% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 4
|
7.2% |
8/26/2025
Event 6/30/2025
|
|
| RA Capital Management, L.P. | 7.2% | ||
| Peter Kolchinsky | 7.2% | ||
| Rajeev Shah | 7.2% | ||
| RA Capital Healthcare Fund, L.P. | 6.9% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 3
|
0% |
8/14/2025
Event 6/30/2025
|
|
| RA Capital Management, L.P. | 0% | ||
| Peter Kolchinsky | 0% | ||
| Rajeev Shah | 0% | ||
| RA Capital Healthcare Fund, L.P. | 0% | ||
|
Adage Capital Management, L.P.
13G
|
5.3% |
8/12/2025
Event 6/30/2025
|
|
| Adage Capital Management, L.P. | 5.3% | ||
| Robert Atchinson | 5.3% | ||
| Phillip Gross | 5.3% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 2
|
7.2% |
5/15/2025
Event 3/31/2025
|
|
| RA Capital Management, L.P. | 7.2% | ||
| Peter Kolchinsky | 7.2% | ||
| Rajeev Shah | 7.2% | ||
| RA Capital Healthcare Fund, L.P. | 6.9% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 1
|
9.9% |
2/14/2025
Event 12/31/2024
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.7% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 1
|
73.6% |
2/14/2025
Event 12/31/2024
|
|
| Perceptive Advisors LLC | 73.6% | ||
| Joseph Edelman | 73.6% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 72.6% | ||
| C2 Life Sciences LLC | 1.0% |